Abciximab readministration: A single-operator community-hospital experience

Catheterization and Cardiovascular Interventions

Volumn 47, Issue 3, 1999, Pages 294-296

  Arjomand, Heidar ^a   Magsi, Zafar M ^a   Chang, Khai S ^a   Mascarenhas, Daniel A N ^a,b  

^a EASTON HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

Abciximab; Bleeding; Repeat administration; Thrombocytopenia

Indexed keywords

ABCIXIMAB;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEART MUSCLE ISCHEMIA; HEMOGLOBIN DETERMINATION; HUMAN; IMMUNOTHERAPY; MALE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ANGINA PECTORIS; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; FEMALE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETREATMENT; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; TIME FACTORS;

EID: 0033016575     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1522-726x(199907)47:3<294::aid-ccd7>3.0.co;2-q     Document Type: Article

References (9)

1. Coller BS. Blockade of platelet GP IIb/IIIa receptors as an antithrombotic strategy. Circulation 1995;92:2373-2380.
2. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoprotein IIb and/or IIIa. J Clin Invest 1983;72:325-338.
3. Adgey AAJ. An overview of the results of clinical trials with glycoprotein IIb/IIIa inhibitors. Am Heart J 1998;135:S43-S55.
4. Ferguson JJ, Kereiakes DJ, Adgey AAJ, Fox KAA, Hillegass Jr WB, Pfisterer M, Vassanelli C. Safe use of platelet GP IIb/IIIa inhibitors. Am Heart J 1998;135:S77-S89.
5. The EPIC Investigators. Use of monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-961.
6. Mascarenhas DAN, Chang KS. Experience with abciximab on re-administration. Am J Cardiol 1997;80:S62.
7. Fry ETA, Hermiller JB, Peters TF, Orr CM, Nasser TK, Erner B, Van Tassel J, Pinkerton CA. Safety and efficacy of repeat administration of abciximab (ReoPro) is equivalent to initial treatment. Circulation 1997;96:I161.
8. Madan M, Kereiakes DJ, Rund M, Anderson L, McDonald MB, Tudor G, Berkowitz SD, Sketch MH Jr, Phillips HR, Tcheng JE. Abciximab readministration for coronary interventions: is it safe? Circulation 1997;96:I162.
9. 3). J Am Coll Cardiol 1998;31:55A.